Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
Cetuximab
open-in-new
<p>Cetuximab, sold under the brand name Erbitux, is an <a href="/facts/Epidermal_growth_factor_receptor/NLmnXKYY">epidermal growth factor receptor</a> (EGFR) inhibitor <a href="/facts/Medication/h9mhwWP2">medication</a> used for the treatment of metastatic <a href="/facts/Colorectal_cancer/nV592sW7">colorectal cancer</a> and <a href="/facts/Head_and_neck_cancer/v8T8bNs7">head and neck cancer</a>. Cetuximab is a chimeric (mouse/human) <a href="/facts/Monoclonal_antibodies/4rUBWB87">monoclonal antibody</a> given by <a href="/facts/Intravenous_infusion/AwwuD3Nu">intravenous infusion</a>. </p><p>Cetuximab was approved for medical use in the United States in 2004. </p>